Suppr超能文献

通过尺寸控制改善细胞封装。

Improving cell encapsulation through size control.

作者信息

Canaple Laurence, Rehor Annemie, Hunkeler David

机构信息

Laboratory of Polyelectrolytes and Biomacromolecules, Swiss Federal Institute of Technology, Lausanne.

出版信息

J Biomater Sci Polym Ed. 2002;13(7):783-96. doi: 10.1163/156856202760197410.

Abstract

Capsules based on the polyelectrolyte complexation between the polyanions sodium alginate and sodium cellulose sulphate with the polycation poly(methylene-co-guanidine) hydrochloride in the presence of calcium chloride have previously shown important advantages for cell encapsulation. However, in vivo long-term applications require capsule features that are well suited for the functionality of encapsulated cells. These should be targeted to the site of implantation with an appropriate size, a relative stability, and suitable diffusion properties. This study shows the effect of capsule size reduction, from 1 mm to 400 microm, on capsule quality control, mechanical stability, diffusion properties, and in vitro activities of the encapsulated cells. Following a controlled preparation, it was determined that the capsule mechanical stability was largely dependent on the volume ratio of the capsule over the membrane. The molecule diffusion time was related to the surface/volume ratio of the capsule even for the capsules exhibiting an identical cut-off towards the proteins and the dextran molecules. Finally, the in vitro cellular activities, for both primary cultures of rat islets and murine hepatocytes, were improved for cells encapsulated into the 400 microm capsules compared with those in the 1 mm capsules. All of these findings suggest that the smaller capsules present better properties for future clinical applications, at the same time widening the choice of implantation site, and strengthen the notion that slight changes in the capsular morphological parameters can largely influence the graft function in vivo.

摘要

基于聚阴离子海藻酸钠和硫酸纤维素钠与聚阳离子聚(亚甲基 - 共 - 胍)盐酸盐在氯化钙存在下的聚电解质络合作用制备的胶囊,此前已显示出在细胞封装方面具有重要优势。然而,体内长期应用需要胶囊具有适合封装细胞功能的特性。这些特性应使胶囊以合适的尺寸、相对稳定性和适当的扩散特性靶向植入部位。本研究展示了将胶囊尺寸从1毫米减小到400微米对胶囊质量控制、机械稳定性、扩散特性以及封装细胞体外活性的影响。经过可控制备后,确定胶囊的机械稳定性在很大程度上取决于胶囊与膜的体积比。即使对于对蛋白质和葡聚糖分子具有相同截留值的胶囊,分子扩散时间也与胶囊的表面积/体积比有关。最后,与封装在1毫米胶囊中的细胞相比,封装在400微米胶囊中的大鼠胰岛原代培养细胞和小鼠肝细胞的体外细胞活性均有所提高。所有这些发现表明,较小的胶囊在未来临床应用中具有更好的性能,同时拓宽了植入部位的选择范围,并强化了这样一种观念,即胶囊形态参数的微小变化可在很大程度上影响体内移植功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验